Pulmonary Hypertension: A Cancerous Proliferative Vascular Disorder?

All credit to Prof. Serge Adnot, Professor of Physiology at INSERM, Creteil, France

Part 3

Additional key-words: malignancy,clinical trials,serotonin

About the author

France

France

Authors: Cacciatore G, Poletti L, Sforza C Source: Prog Orthod

Authors: Aguero J, Hammoudi N, Bikou O, Fish KM, Zarragoikoetxea I, Hajjar RJ, Ishikawa K Source: Methods Mol Biol

Authors: Huang L, Liu W, Jiang Q, Zuo Y, Su Y, Zhao L, Qin Y, Yan Q Source: Front Cell Infect Microbiol

Authors: Kurysheva NI, Maslova EV, Trubilina AV, Fomin AV, Lagutin MB Source: Vestn Oftalmol

Authors: Gorter TM, Obokata M, Reddy YNV, Melenovsky V, Borlaug BA Source: Eur Heart J

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI